Njengomugqa wokuqala owenziwe nge-Film-coating ukukhiqizwa ngomugqa we-FDA, lokwakheka okusha okuqhakambisa izici zokuchithwa okusheshayo kanye nokumunca endaweni yomlomo, ukuhlinzeka ngesisombululo semithi yomlomo, ukukhombisa izinzuzo zokugwinya. Ukudlula ngempumelelo kokuhlolwa kwesayithi likaFDA akubonisi amandla ama-Lipin Pharmas 'ekwenzeni ulwazi olusha lokucwaninga nokukhiqiza kodwa futhi kubonisa ukuzibophezela kwalo okuqinile ekubambeni okuqinile kumazinga alawulwa ezidakamizwa ahlukahlukene.
Kuyafaneleka ukusho ukuthi yonke imishini ye-lipin pharmas 'Ulayini wokukhiqiza we-Oral Pharmas' unikezwaUkukhiqiza ubuchwepheshe obuqondanisiwe. Njengomhlinzeki omaka owodwa wefilimu elihlaselwa ngomlomo, ubuchwepheshe obuqondanisiwe abagcini ngokucwaninga kanye namakhono okukhiqiza okusebenza okugcwele kwemishini kodwa futhi basebenzisana nabalingani abasezingeni eliphezulu naphansi ukunikela ngezinsizakalo eziphelele zokusekelwa kwemishini.
Siyahlonishwa futhi ukuthi uLipin Pharma ukhethe imishini yethu. Ngobuchwepheshe bethu obuthuthukisiwe, umugqa wokukhiqiza we-lipin pharmas manje ujabulela ukuqinisekiswa okuphezulu, ukuqina okuthuthukile, kanye nokusebenza kahle. Lokhu kuhlangana kwe -rerscores kuqondaniswe nobuchwepheshe bokuzibophezela kwezobuchwepheshe ekuhlinzekeni imishini eqinile yocwaningo kanye nokukhiqizwa kwezindlela ezintsha. Ngaphezu kwalokho, lokhu kusebenzisana okuvelele kubeka isisekelo esiqinile sokuthuthuka okujulile ngokuzayo.
Njengoba imakethe yezemithi yomhlaba iyaqhubeka nokuvela futhi ukuncintisana kuyaqina, i-lipin pharma izoqhubeka nokuqinisa ukuhlanganiswa kwayo namazinga aphesheya, ngokuqhubekayo ukuthuthukisa amazinga alo we-R & D, futhi ithuthukise amazinga awo okukhiqiza, futhi athuthukise amazinga awo okukhiqiza, futhi athuthukise amazinga awo okukhiqiza, futhi athuthukise amazinga awo okukhiqiza, futhi athuthukise amazinga awo okukhiqiza, futhi athuthukise amazinga alo okukhiqiza. Ngasikhathi sinye, i-Lipin Pharma izosebenzisa amandla ngentshiseko ukubambisana namabhizinisi avelele ukukhuthaza ukuthuthukiswa okusha kwemboni yemithi yaseChina futhi kuthuthukise ukuncintisana kwayo kwamazwe aphesheya.
Umugqa wokukhiqiza ophumelele we-FDA ophumelele we-Oral Diskuva wefilimu ukukhiqiza uphawu olunye lwe-lipin pharma ohambweni lwalo olusha, futhi usho ukubaluleka kokubambisana phakathi kwe-Lipin Pharma kanye ne-Alignated Technology enkundleni yezemithi. Esikhathini esizayo, ubuchwepheshe obuqondanisiwe bubheke phambili ekuqhubekeni kokuthola izinzuzo zalo ezintsha nge-lipin pharma ukuletha imikhiqizo esezingeni eliphakeme yemithi emhlabeni wonke futhi yenza iminikelo enkulu embonini yezemithi yaseChina.
Isikhathi sePosi: APR-25-2024